Dimensional Fund Advisors
IPSC icon

Dimensional Fund Advisors’s Century Therapeutics IPSC Stock Holding History

Dimensional Fund Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
+55,183
New +$116K ﹤0.01% 3102
2025
Q2 		– Sell
-26,735
Closed -$12.8K – 3299
2025
Q1 		$12.8K Sell
26,735
-139
-0.5% -$104 ﹤0.01% 3313
2024
Q4 		$27.1K Sell
26,874
-6,575
-20% -$8.95K ﹤0.01% 3322
2024
Q3 		$56.9K Sell
33,449
-41,866
-56% -$82K ﹤0.01% 3288
2024
Q2 		$192K Buy
75,315
+44,155
+142% +$140K ﹤0.01% 3172
2024
Q1 		$130K Sell
31,160
-1,438
-4% -$6.09K ﹤0.01% 3234
2023
Q4 		$108K Buy
32,598
+4,572
+16% +$8.33K ﹤0.01% 3272
2023
Q3 		$56.1K Sell
28,026
-2,465
-8% -$6.56K ﹤0.01% 3369
2023
Q2 		$96.4K Sell
30,491
-8,962
-23% -$28.9K ﹤0.01% 3328
2023
Q1 		$137K Sell
39,453
-24,857
-39% -$109K ﹤0.01% 3265
2022
Q4 		$330 Buy
64,310
+26,870
+72% +$254K ﹤0.01% 3118
2022
Q3 		$370K Buy
+37,440
New +$394K ﹤0.01% 3107

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Dimensional Fund Advisors's IPSC Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Century Therapeutics (IPSC) in Q1 2026: 55,183 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #3102 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in IPSC as recently as Q1 2025.

Dimensional Fund Advisors first reported a position in IPSC in Q3 2022 and has held it in 12 quarters since. The position peaked at $370K in Q3 2022. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Dimensional Fund Advisors held 55,183 shares of Century Therapeutics worth $122K as of Q1 2026.
  • Century Therapeutics was a new Dimensional Fund Advisors position in Q1 2026.
  • Century Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3102 holding.
  • Dimensional Fund Advisors first reported a position in Century Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • Dimensional Fund Advisors's Century Therapeutics position peaked at $370K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.